Complete Response to Systemic Treatment Might Predict Better Survival Rates Regardless of Their Metastatic Patterns in De Novo Stage IV Breast Cancer Patients Undergoing Primary Surgery

European Journal of Surgical Oncology - United Kingdom

doi 10.1016/j.ejso.2019.08.006